Immunovant Stock Investor Trims Stake, Still Bullish
Immunovant stock surged about 30% after a fund trimmed its stake by roughly $3 million. This article explains why the...
Small-cap volatility can threaten predictable retirement income. This note covers swing risk and how to cushion portfolios with prudent diversification.
23,862 articlesImmunovant stock surged about 30% after a fund trimmed its stake by roughly $3 million. This article explains why the...
When a CEO disposes of stock, investors want context. This deep dive explains what fastly's sold company shares could...
Oracle is pursuing aggressive growth through heavy spending. This article breaks down the rationale, the risks, and w...
Mortgage rates rose again as Iran-related tensions amplify inflation fears, complicating borrowing for homebuyers and...
A major European energy firm plans to halt offshore wind projects off the U.S. East Coast and redirect about $1B into...
As AI reshapes business, three stock ideas stand out for potential multi-year gains. This guide breaks down why, how ...
Trifecta of forecasts from the leading claude price prediction tie Bitcoin, Solana and XRP to live market catalysts. ...
A focused look at Toast's Q1 2026 results and what they imply for toast (tost) 2026 earnings. Expect discussion of re...
Beyond Meat's stock has faced a steep slide, but the plant-based meat story isn’t closed. This guide breaks down the ...
Lulu's LVLU is shaping its 2026 earnings story through stronger direct channels, smarter pricing, and inventory disci...
A contrarian approach that looks beyond flashy tech names. Learn how to find a dirt cheap growth stock with solid fun...
In a year of volatile rates, Vanguard’s cheapest short-term bond ETF stands out for ultra-low fees and solid near-ter...